keyword
https://read.qxmd.com/read/38651851/skin-changes-in-suspected-lyme-disease
#1
JOURNAL ARTICLE
Pero Vržogić, Ante Perica
Dear Editor, Ticks carry many diseases, bacteria, and viruses and represent a very important healthcare issue both in Croatia and globally. Although most ticks are not infected with pathogens dangerous to humans, some ticks can transmit infectious diseases with significant morbidity and mortality. This is caused by the increasing incidence of many tick-borne diseases over a growing geographical area. Many factors influence which species of ticks are present in a given geographical area, as well as the density of their population and the risk of human exposure to infected ticks...
December 2023: Acta Dermatovenerologica Croatica: ADC
https://read.qxmd.com/read/38650882/causal-associations-between-gut-microbiota-and-cutaneous-melanoma-a-mendelian-randomization-study
#2
JOURNAL ARTICLE
Yan-Qiu Bao, Ying Zhang, Zhou-Na Li
BACKGROUND: Cutaneous melanoma (CM) of the skin stands as the leading cause of mortality among skin cancer-related deaths. Despite the successes achieved with novel therapies such as immunotherapy and targeted therapy, their efficacy remains limited, necessitating further exploration of new treatment modalities. The gut microbiota and CM may be linked, as indicated by a growing body of preclinical and observational research. Nevertheless, the exact correlation between the intestinal microbiota and CM remains to be determined...
2024: Frontiers in Microbiology
https://read.qxmd.com/read/38650592/vitiligo-like-amelanotic-melanoma-in-situ-a%C3%A2-rare-presentation
#3
Lilia Maria Lima de Oliveira, Uzma Farooq, Naiara Fraga Braghiroli
No abstract text is available yet for this article.
May 2024: JAAD Case Reports
https://read.qxmd.com/read/38650494/melanoma-epidemiology-in-europe-what-is-new
#4
JOURNAL ARTICLE
Luana A Nurla, Ana-Maria Forsea
Every year in Europe over 150,000 new cases of melanoma are reported and over 25,000 lives are lost to this tumor. Incidence has been rising rapidly, faster than for any other cancer, and it is expected to continue to do so in most regions. Mortality also crept up, decades-long, with only few very recent exceptions. Thus, melanoma remains a public health problem that will not go away soon, nor easy. Some notable progress has been made in the last decade in the fight against this tumor. Registration and reporting for skin cancers improved across Europe...
April 2024: Italian journal of dermatology and venereology
https://read.qxmd.com/read/38648931/-translated-article-discussion-abounds-on-the-potential-carcinogenic-risks-associated-with-the-use-of-uv-curing-lamps-for-permanent-nail-polish
#5
JOURNAL ARTICLE
J Aguilera, R J Bosch, M V de Gálvez
BACKGROUND: Controversy has recently broken out over the potential carcinogenic risk associated with exposure to UV lamps for permanent nail polish. The new LED-based polymerization devices, and their potential biological effect has not been analyzed to this date. OBJECTIVE: To evaluate the emission power and its potential biological effects on the skin of 2 types of UV LED and fluorescent curing lamps under normal use conditions compared to doses of sunlight exposure...
April 20, 2024: Actas Dermo-sifiliográficas
https://read.qxmd.com/read/38646861/comparison-of-skin-cancer-risk-between-renal-transplant-recipients-and-patients-with-glomerular-diseases-in-rural-queensland
#6
JOURNAL ARTICLE
Zaw Thet, Alfred King-Yin Lam, Shu-Kay Ng, Soe Yu Aung, Thin Han, Dwarakanathan Ranganathan, Stephanie Newsham, Jennifer Borg, Christine Pepito, Tien K Khoo
INTROUDCTION: There is increased risk of skin cancer in patients with gloermular disease or those with renal transplant. OBJECTIVES: To compare the risk of skin cancer between kidney recipients (KTRs) and patients with glomerular disease (GD). DESIGN: The cohort comprised patients with KTRs (n = 61) and GD (n = 51) in Central and Central West Queensland, Australia. A quantitative cohort study was undertaken to study the risk of skin cancer in rural communities between two subgroups of patients with kidney diseases in relationship to immunosuppression...
April 2024: Australian Journal of Rural Health
https://read.qxmd.com/read/38644305/-%C3%A2-update-on-systemic-therapies-for-melanoma-and-non-melanoma-skin-cancers
#7
JOURNAL ARTICLE
Kenjiro Namikawa
No abstract text is available yet for this article.
April 2024: Gan to Kagaku Ryoho. Cancer & Chemotherapy
https://read.qxmd.com/read/38644303/-melanoma-and-non-melanoma-skin-cancers
#8
JOURNAL ARTICLE
Hisashi Uhara
No abstract text is available yet for this article.
April 2024: Gan to Kagaku Ryoho. Cancer & Chemotherapy
https://read.qxmd.com/read/38643380/representation-of-skin-carcinomas-in-public-awareness-awareness-worldwide-and-in-germany
#9
JOURNAL ARTICLE
Anne Meinzenbach, Martin Kaatz, Steffen Springer, Michael Zieger
BACKGROUND AND OBJECTIVES: In recent years, there has been an increase in skin cancer. The aim of this study was therefore to investigate the representation of skin cancer in public awareness worldwide and in Germany, and to determine whether Skin Cancer Awareness Month is represented in the search interests of the Internet-using population in the same way as Breast Cancer Awareness Month worldwide. DATA AND METHODS: In this study, Google Trends data were used to track levels of public awareness for different tumor entities and skin cancer types worldwide and for Germany...
April 21, 2024: Journal der Deutschen Dermatologischen Gesellschaft: JDDG
https://read.qxmd.com/read/38638856/editorial-advances-in-molecular-and-pharmacological-mechanisms-of-novel-targeted-therapies-for-melanoma
#10
EDITORIAL
Marcel Henrique Marcondes Sari, Luana Mota Ferreira
No abstract text is available yet for this article.
2024: Frontiers in Oncology
https://read.qxmd.com/read/38638187/dermatology-by-dermatologists
#11
JOURNAL ARTICLE
David Crasto, Drew Taylor, Eduardo Weiss, Stanislav Tolkachjov
No abstract text is available yet for this article.
April 2024: Journal of Clinical and Aesthetic Dermatology
https://read.qxmd.com/read/38635829/geraniol-and-citral-recent-developments-in-their-anticancer-credentials-opening-new-vistas-in-complementary-cancer-therapy
#12
REVIEW
Gauri Srivastava, Esha Mukherjee, Ruchika Mittal, Deepak Ganjewala
About 10 million people are diagnosed with cancer each year. Globally, it is the second leading cause of death after heart disease, and by 2035, the death toll could reach 14.6 million. Several drugs and treatments are available to treat cancer, but survival rates remain low. Many studies in recent years have shown that plant-derived monoterpenes, particularly geraniol and citral, are effective against various cancers, including breast, liver, melanoma, endometrial, colon, prostate, and skin cancers. This trend has opened new possibilities for the development of new therapeutics or adjuvants in the field of cancer therapy...
April 19, 2024: Zeitschrift Für Naturforschung. C, A Journal of Biosciences
https://read.qxmd.com/read/38635572/incidence-rates-of-the-most-common-canine-tumors-based-on-data-from-the-swiss-canine-cancer-registry-2008-to-2020
#13
JOURNAL ARTICLE
Elena Sophie Dhein, Ulla Heikkilä, Anna Oevermann, Sohvi Blatter, Daniela Meier, Sonja Hartnack, Franco Guscetti
Monitoring neoplasms in standardized registries facilitates epidemiologic studies of risk factors for tumor development and predisposition. In an observational study, we determined incidence rates (IR) and malignant tumor incidence rate ratios (IRR) by age, sex, and breed in Swiss dogs using demographic data from the official Swiss dog registration database Amicus. The dataset analyzed included 54'986 tumors diagnosed by histology and cytology in four Swiss veterinary pathology laboratories between 2008 and 2020...
2024: PloS One
https://read.qxmd.com/read/38634738/difference-in-computer-assistance-effects-on-human-doctor-accuracy-in-diagnosing-acral-and-non-acral-pigmented-skin-tumors
#14
JOURNAL ARTICLE
Akane Minagawa, Hiroshi Koga, Kazuhisa Matsunaga, Akira Hamada, Ryuhei Okuyama
No abstract text is available yet for this article.
April 18, 2024: Journal of Dermatology
https://read.qxmd.com/read/38633930/sunscreen-safety-and-efficacy-for-the-prevention-of-cutaneous-neoplasm
#15
REVIEW
Jonathan R Raymond-Lezman, Suzanne I Riskin
Sunscreen is widely used for ultraviolet radiation protection. Studies validate sun protection factors (SPFs) to prevent ultraviolet (UV)-induced skin changes such as melanoma and squamous cell carcinoma (SCC). Few studies examine sunscreen's impact on endocrine and immune system dysregulation, the production of radical oxygen species, and whether the ingredients deteriorate under prolonged exposure. We present an investigation of sunscreen labels and how ingredients impact sun safety and human health. A review of the literature was conducted using Embase and PubMed to examine sunscreen safety, efficacy, and use to prevent UV-induced skin damage...
March 2024: Curēus
https://read.qxmd.com/read/38633624/distinct-roles-of-cd244-expression-in-cancer-diagnosis-and-prognosis-a-pan-cancer-analysis
#16
JOURNAL ARTICLE
Zhenzhen Deng, Yuanhong Liu, Haiyan Zhou
The abnormal expression of tumor associated genes in pan-cancer is closely related to the clinicopathological features of distinct cancer types. Thus, identifying the role of specific genes in pan-cancer is needed for developing effective anti-cancer strategies. However, the function of CD244 in pan-cancer has not been fully understood. In this study, we explored the CD244 expression profile across 33 tumor types based on The Cancer Genome Atlas project, the Gene Expression Omnibus database, and other bioinformatics tools...
April 15, 2024: Heliyon
https://read.qxmd.com/read/38631706/tumor-targeted-therapy-with-braf-inhibitor-recruits-activated-dendritic-cells-to-promote-tumor-immunity-in-melanoma
#17
JOURNAL ARTICLE
Florian Hornsteiner, Janine Vierthaler, Helen Strandt, Antonia Resag, Zhe Fu, Markus Ausserhofer, Christoph H Tripp, Sophie Dieckmann, Markus Kanduth, Kathryn Farrand, Sarah Bregar, Niloofar Nemati, Natascha Hermann-Kleiter, Athanasios Seretis, Sudhir Morla, David Mullins, Francesca Finotello, Zlatko Trajanoski, Guido Wollmann, Franca Ronchese, Marc Schmitz, Ian F Hermans, Patrizia Stoitzner
BACKGROUND: Tumor-targeted therapy causes impressive tumor regression, but the emergence of resistance limits long-term survival benefits in patients. Little information is available on the role of the myeloid cell network, especially dendritic cells (DC) during tumor-targeted therapy. METHODS: Here, we investigated therapy-mediated immunological alterations in the tumor microenvironment (TME) and tumor-draining lymph nodes (LN) in the D4M.3A preclinical melanoma mouse model (harboring the V-Raf murine sarcoma viral oncogene homolog B (BRAF)V600E mutation) by using high-dimensional multicolor flow cytometry in combination with multiplex immunohistochemistry...
April 17, 2024: Journal for Immunotherapy of Cancer
https://read.qxmd.com/read/38630598/prediction-of-deleterious-non-synonymous-snps-of-human-mdc1-gene-an-in-silico-approach
#18
JOURNAL ARTICLE
Vaishnavee Thote, Susha Dinesh, Sameer Sharma
MDC1 (Mediator of DNA damage Checkpoint protein 1) functions to facilitate the localization of numerous DNA damage response (DDR) components to DNA double-strand break sites. MDC1 is an integral component in preserving genomic stability and appropriate DDR regulation. There haven't been systematic investigations of MDC1 mutations that induce cancer and genomic instability. Variations in nsSNPs have the potential to modify the protein chemistry and their function. Describing functional SNPs in disease-associated genes presents a significant conundrum for investigators, it is possible to assess potential functional SNPs before conducting larger population examinations...
December 2024: Systems Biology in Reproductive Medicine
https://read.qxmd.com/read/38629891/skin-cancer-risk-of-narrow-band-uv-b-tl-01-phototherapy-a-multi-center-registry-study-with-4-815-patients
#19
MULTICENTER STUDY
Petra Åkerla, Eero Pukkala, Mika Helminen, Niina Korhonen, Toni Karppinen
Narrow-band TL-01 ultraviolet B phototherapy (TL-01) is an effective and widely used treatment for many skin diseases. The purpose of the investigation was to assess the risk of skin cancers in patients treated with TL-01 phototherapy who have not received any other phototherapy modalities. This cohort study included 4,815 TL-01 treated patients in Finland with psoriasis or atopic dermatitis. Clinical information was collected from the hospital records and linked with Finnish Cancer Registry data. The follow-up started from the first TL-01 treatment and the mean follow-up time was 8...
April 17, 2024: Acta Dermato-venereologica
https://read.qxmd.com/read/38629283/skin-cancer-occurrence-single-center-experiences-from-period-2020-2022
#20
JOURNAL ARTICLE
Łukasz Łaziński, Mateusz Koziej, Bogusław Antoszewski, Marta Fijałkowska
<b><br>Introduction:</b> Skin cancers constitute a group of medical disorders remaining a field of interest for surgeons and dermatologists. Currently, this group is typically divided into malignant melanoma (MM) and keratinocyte cancers (KC).</br> <b><br>Aim:</b> The aim of this study is to analyze the cases of skin cancers treated in the Department of Plastic, Reconstructive, and Aesthetic Surgery in Lodz (Poland) during the COVID-19 pandemic (from 2020 to 2022) and then compare the results with the ones from the pre-pandemic period (from 2017 to 2019)...
October 12, 2023: Polski Przeglad Chirurgiczny
keyword
keyword
102731
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.